Viemed Healthcare, Inc. (NASDAQ: VMD)

VIEMED Healthcare, Inc., a company that trades under the stock symbol VMD on the NASDAQ, operates in the home medical equipment (HME) and post-acute respiratory healthcare services industry in the United States. The company is dedicated to the growth of its business and establishing itself as one of the leading providers of home therapy for patients with severe respiratory diseases.

VIEMED's primary services include respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. These services are provided to patients by respiratory therapists who are licensed members of the American Association for Respiratory Care. This licensure and AARC membership ensures that VIEMED can offer patients in-home respiratory care services, equipment setup, training, and on-call services with state-of-the-art clinical protocols.

The company sources hardware from vendors and pairs them with industry-leading respiratory therapy. VIEMED historically funded patient-related capital expenditures through cash generated from operations or financing through an affiliate of its primary vendors. The company's existing commercial credit facilities have a total borrowing capacity of up to $90 million, which can be used for financing patient-related capital expenditures.

Being a significant player in the HME industry, VIEMED faces competition from Apria Healthcare, Inc., Lincare Holdings Inc., and ResMed Inc. However, the company has several competitive advantages, including its focus on respiratory disease management, its ability to provide high-touch services to patients, and its strong relationships with payors and healthcare providers.

VIEMED's customers include patients suffering from respiratory diseases, healthcare providers, and payors. The company's patient base is diverse and spread across all 50 states in the United States.

In terms of government regulation, VIEMED is subject to the Centers for Medicare and Medicaid Services ("CMS") Medicare National Coverage Determinations Manual, which requires providers of products or services to attain and maintain accreditation in order to participate in federally funded healthcare programs. The company is also subject to the Federal Anti-Kickback Statute, the Stark Law, and the Federal False Claims Act, among other laws and regulations.

VIEMED is also subject to the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), which established uniform standards governing the conduct of certain electronic healthcare transactions and protecting the security and privacy of individually identifiable health information maintained or transmitted by healthcare providers, health plans, and healthcare clearinghouses. The company is also subject to the Health Information Technology for Economic and Clinical Health Act of 2009 ("HITECH"), which made HIPAA's privacy and security standards directly applicable to business associates of covered entities.

As an emerging growth company, as defined in the Jumpstart Our Business Startups Act (the "JOBS Act"), VIEMED can take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies.